Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

This study has been completed.
Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa
Triclinium Johannesburg, South Africa
University of Stellenbosch
HJ-CTC George, South Africa
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH Identifier:
First received: November 18, 2011
Last updated: October 28, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)